Known and emerging biomarkers of leptomeningeal metastasis and its response to treatment. - Wikidata - wikimedia - TriplyDB

Known and emerging biomarkers of leptomeningeal metastasis and its response to treatment.

Known and emerging biomarkers of leptomeningeal metastasis and its response to treatment.

http://www.wikidata.org/entity/Q37690311

about

Development of a new method for identification and quantification in cerebrospinal fluid of malignant cells from breast carcinoma leptomeningeal metastasis Leptomeningeal metastasis: a Response Assessment in Neuro-Oncology critical review of endpoints and response criteria of published randomized clinical trials Leptomeningeal metastases: a RANO proposal for response criteria.Neuro-ophthalmologic complications of neoplastic leptomeningeal disease.How to recognize and treat neoplastic meningitis.Proteomic analysis of cerebrospinal fluid from children with central nervous system tumors identifies candidate proteins relating to tumor metastatic spread.Complement Component 3 Adapts the Cerebrospinal Fluid for Leptomeningeal Metastasis.

P2860

Q34474896-5F47BC4B-51A3-456D-9146-2446F0812464 Q35175149-FBE49A9C-F3DE-4DF6-BBB0-CF4F9119AC39 Q36236770-F97BCEB2-DB83-41F2-9950-BFF01E2D8557 Q38155430-44A3648E-A855-4C8C-AFF5-7EDC40F551C6 Q38230425-A1AE14A4-87DE-4075-B8E3-9DFDEF132D62 Q38702839-9CEA0134-5019-41BC-922C-2FF7B8378BCE Q48269323-C16DCF8A-CCCF-4A21-B80E-06F1635AA5CD

P2860

Known and emerging biomarkers of leptomeningeal metastasis and its response to treatment.

http://www.wikidata.org/entity/Q37690311

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on February 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Known and emerging biomarkers of leptomeningeal metastasis and its response to treatment.

@en

Known and emerging biomarkers of leptomeningeal metastasis and its response to treatment.

@nl

type

label

Known and emerging biomarkers of leptomeningeal metastasis and its response to treatment.

@en

Known and emerging biomarkers of leptomeningeal metastasis and its response to treatment.

@nl

prefLabel

Known and emerging biomarkers of leptomeningeal metastasis and its response to treatment.

@en

Known and emerging biomarkers of leptomeningeal metastasis and its response to treatment.

@nl

P1433

Q37690311-ADB903BB-ACAC-4241-93D3-16A0CB95E359

P1476

Q37690311-E558BC02-F53C-4E90-BC76-46E469438CA9

P2093

Q37690311-0D8FB7A2-3CF3-4796-9C96-9303DE9B57B2

Q37690311-790EA386-E915-449D-A163-63E6E67D1E02

P2860

Q37690311-06A832F7-EF91-4314-8691-5E4BABC52213

Q37690311-238B95F4-305A-4379-B54A-C4F88C75816E

Q37690311-2678CEB1-B092-4928-B393-8EED46F3F0E1

Q37690311-27ED2CC8-2C39-4F92-BD37-E510FA41A7A5

Q37690311-2BCA9AE2-3CC7-4F1A-AAB6-5D13113D7342

Q37690311-39913C17-AB3F-42BF-A0DE-A68A3B23DD1B

Q37690311-3CEF2E4C-3940-4657-AC4A-2D598AB1DBDB

Q37690311-4B0226D5-9E13-4813-91D9-D2D5DEBF43A9

Q37690311-4C60B89D-47BF-4729-9441-77A39CE68419

Q37690311-4C806099-AEC2-4EB9-8838-424A8F5DFDCA

P304

Q37690311-E8AEE00C-39A4-4E37-8A8F-2DC9116E18EE

P31

Q37690311-0FDB8AA0-6E67-46A8-AECA-1A87B53352BF

P356

Q37690311-AB654DD0-8497-43AF-9D2C-6A0D8EF3DEC8

P407

Q37690311-3A2FE1C8-A509-4504-880E-7E9E8851F569

P433

Q37690311-E42C599B-71A1-4912-9937-19EFE61AED46

P478

Q37690311-2489CE75-802F-4AFE-AC44-F6F8C0266219

P577

Q37690311-B47475B7-2D69-446F-8210-72AF24836CE9

P698

Q37690311-112AE099-46B3-4697-A967-A760E2B5A966

P921

Q37690311-E5A57D41-9955-4FE5-8AB3-B8E11BCD05EF

P356

P1433

Future Oncology

P1476

Known and emerging biomarkers of leptomeningeal metastasis and its response to treatment.

@en

P2093

Morris D Groves

http://www.w3.org/2001/XMLSchema#string

Tobias Walbert

http://www.w3.org/2001/XMLSchema#string

P2860

Involvement of chemokine receptors in breast cancer metastasis

DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

Intrathecal treatment of neoplastic meningitis due to breast cancer with a slow-release formulation of cytarabine

Diagnostic protein discovery using proteolytic peptide targeting and identification.

Posterior fossa metastases: risk of leptomeningeal disease when treated with stereotactic radiosurgery compared to surgery.

MALDI-TOF mass spectrometry analysis of cerebrospinal fluid tryptic peptide profiles to diagnose leptomeningeal metastases in patients with breast cancer.

Identification of leptomeningeal metastasis-related proteins in cerebrospinal fluid of patients with breast cancer by a combination of MALDI-TOF, MALDI-FTICR and nanoLC-FTICR MS.

CSF flow cytometry greatly improves diagnostic accuracy in CNS hematologic malignancies.

Protein biomarker identification in the CSF of patients with CNS lymphoma.

P304

287-297

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/FON.09.167

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2010-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20146587

http://www.w3.org/2001/XMLSchema#string

P921